PMID- 9928439 OWN - NLM STAT- MEDLINE DCOM- 19990224 LR - 20190616 IS - 0077-8923 (Print) IS - 0077-8923 (Linking) VI - 854 DP - 1998 Nov 20 TI - Age-associated memory impairment. Assessing the role of nitric oxide. PG - 307-17 AB - Several neurotransmitter systems have been investigated to assess hypothesized mechanisms underlying the decline in recent memory abilities in normal aging and in Alzheimer's disease. Examining the performance of F344 rats in a 14-unit T-maze (Stone maze), we have focused on the muscarinic cholinergic (mACh) and the N-methyl-D-aspartate (NMDA) glutamate (Glu) systems and their interactions. Maze learning is impaired by antagonists to mACh or NMDA receptors. We have also shown that stimulation of mACh receptors can overcome a maze learning deficit induced by NMDA blockade, and stimulation of the NMDA receptor can overcome a similar blockade of mACh receptors. No consistent evidence in rats has been produced from our laboratory to reveal significant age-related declines in mACh or NMDA receptor binding in the hippocampus (HC), a brain region that is greatly involved in processing of recent memory. Thus, we have directed attention to the possibility of a common signal transduction pathway, the nitric oxide (NO) system. Activated by calcium influx through the NMDA receptor, NO is hypothesized to be a retrograde messenger that enhances presynaptic Glu release. Maze learning can be impaired by inhibiting the synthetic enzyme for NO, nitric oxide synthase (NOS), or enhanced by stimulating NO release. However, we have found no age-related loss of NOS-containing HC neurons or fibers in rats. Additionally, other laboratories have reported no evidence of an age-related loss of HC NOS activity. In a microdialysis study we have found preliminary evidence of reduced NO production following NMDA stimulation. We are currently working to identify the parameters of this phenomenon as well as testing various strategies for safely stimulating the NO system to improve memory function in aged rats. FAU - Meyer, R C AU - Meyer RC AD - Nathan W. Shock Laboratories, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA. FAU - Spangler, E L AU - Spangler EL FAU - Kametani, H AU - Kametani H FAU - Ingram, D K AU - Ingram DK LA - eng PT - Journal Article PT - Review PL - United States TA - Ann N Y Acad Sci JT - Annals of the New York Academy of Sciences JID - 7506858 RN - 0 (Receptors, Muscarinic) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 31C4KY9ESH (Nitric Oxide) RN - EC 1.14.13.39 (Nitric Oxide Synthase) SB - IM MH - Aging/*physiology/*psychology MH - Animals MH - Hippocampus/growth & development/*physiology MH - *Maze Learning MH - Memory/*physiology MH - *Memory Disorders MH - Models, Neurological MH - Nitric Oxide/*physiology MH - Nitric Oxide Synthase/metabolism MH - Rats MH - Rats, Inbred F344 MH - Receptors, Muscarinic/physiology MH - Receptors, N-Methyl-D-Aspartate/physiology MH - Signal Transduction RF - 62 EDAT- 1999/02/03 00:00 MHDA- 1999/02/03 00:01 CRDT- 1999/02/03 00:00 PHST- 1999/02/03 00:00 [pubmed] PHST- 1999/02/03 00:01 [medline] PHST- 1999/02/03 00:00 [entrez] AID - 10.1111/j.1749-6632.1998.tb09911.x [doi] PST - ppublish SO - Ann N Y Acad Sci. 1998 Nov 20;854:307-17. doi: 10.1111/j.1749-6632.1998.tb09911.x.